HIK.L - Hikma Pharmaceuticals PLC

LSE - LSE Delayed Price. Currency in GBp
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in USD. All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue2,070,0001,936,0001,950,0001,440,000
Cost of Revenue1,066,0001,021,0001,000,000622,000
Gross Profit1,004,000915,000950,000818,000
Operating Expenses
Research Development118,000115,000126,00036,000
Selling General and Administrative464,000474,000429,000352,000
Non Recurring----
Others-7,000-10,000-6,00037,000
Total Operating Expenses1,641,0001,600,0001,549,0001,047,000
Operating Income or Loss429,000336,000401,000393,000
Income from Continuing Operations
Total Other Income/Expenses Net-136,000-1,074,000-191,000-75,000
Earnings Before Interest and Taxes429,000336,000401,000393,000
Interest Expense-41,000-51,000-48,000-40,000
Income Before Tax293,000-738,000210,000318,000
Income Tax Expense8,000101,00052,00064,000
Minority Interest12,00014,00015,00015,000
Net Income From Continuing Ops285,000-839,000158,000254,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income282,000-843,000155,000252,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares282,000-843,000155,000252,000